iAssay Granted US Patent Number 10,309,954 “Assay Apparatus”
SAN DIEGO, CA – June 4, 2019 – iAssay® Inc., a privately held developer of the world’s first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has granted the company US Patent Number 10,309,954. The granted patent includes 66 claims relating to multiple types of patient tests, wireless communications, plug-in modules, and user guide, providing intellectual property protection into 2035.
For more details, see the iAssay press release announcing USPTO Notice of Allowance http://www.digitaljournal.com/pr/4131713
The iAssay® System is the world’s first open platform for wirelessly-connected point of care diagnostics. The functionality of a closet full of single function readers is replaced by one handheld device and adaptor plug-ins, to adapt nearly any point of care test cartridge to the iAssay System. The HIPAA-compliant device aggregates test/patient/wearable biometric data and pushes all data into the cloud. iAssay eliminates multiple daily trips with blood samples to central labs by testing the patient wherever they are. Testing at a clinic or at the patients’ bedside in a few minutes eliminates test result delays (and delayed diagnosis), eliminates sample handling and transportation costs, improves patient outcomes, and saves the healthcare system money.